GlassScriptPhysician profile
Colin M Burnett
NPI 1205284197
$24,928.33
in general payments reported to CMS, 2019-2025
9 companies · $5,388 in 2025
The $5,388 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.66 · 2020: $220 · 2021: $341 · 2022: $10K · 2023: $8,023 · 2024: $623 · 2025: $5,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,000 · Travel and Lodging: $4,938 · Food and Beverage: $3,969 · Education: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,000.00 |
| Travel and Lodging | $4,938.37 |
| Food and Beverage | $3,969.28 |
| Education | $126.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23,490.55 | 2022-2025 | Evera Mri Xt Dr Surescan, Micra, Attain Command + Surevalve |
| Abbott Laboratories | $553.80 | 2020-2025 | Aveir |
| Boston Scientific Corporation | $233.89 | 2019-2025 | Watchman Access System |
| Biotronik INC. | $226.05 | 2021-2025 | |
| Biosense Webster, INC. | $152.55 | 2024 | Carto 3, Qdot Micro Catheter |
| Getinge USA Sales, LLC | $107.45 | 2021-2023 | Cardiohelp |
| Impulse Dynamics (USA) INC. | $105.69 | 2025 | Optimizer |
| Abiomed | $39.39 | 2020-2021 | |
| Janssen Scientific Affairs, LLC | $18.96 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Burnett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.